KRAS Educational session

Phase I trial of RO5126766 a MEK-RAF inhibitor in solid tumours and myeloma driven by RAS driven cancers (ID 51)

Lecture Time
11:45 - 12:05
Speakers
  • U. Banerji
Session Name
KRAS
Location
Amphithéâtre Bordeaux, Palais des Congrès, Paris, France
Date
27.02.2019
Time
11:00 - 12:30
Authors
  • U. Banerji